ONCOPRECISION
We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
ONCOPRECISION
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2020-09-25
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.oncoprecision.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Universal Analytics Apache Mobile Non Scaleable Content Google Apps For Business AJAX Libraries API
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
New York State’s Empire State Development Fund
New York State’s Empire State Development Fund investment in Seed Round - OncoPrecision
Martin Anazco
Martin Anazco investment in Seed Round - OncoPrecision
Creative Ventures
Creative Ventures investment in Seed Round - OncoPrecision
GRID EXPONENTIAL
GRID EXPONENTIAL investment in Seed Round - OncoPrecision
IndieBio
IndieBio investment in Seed Round - OncoPrecision
Diego Meller
Diego Meller investment in Seed Round - OncoPrecision
SOSV
SOSV investment in Seed Round - OncoPrecision
SOSV
SOSV investment in Pre Seed Round - OncoPrecision
GRID EXPONENTIAL
GRID EXPONENTIAL investment in Pre Seed Round - OncoPrecision
Official Site Inspections
http://www.oncoprecision.bio Semrush global rank: 4.39 M Semrush visits lastest month: 2.55 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OncoPrecision"
OncoPrecision - What if drug discovery started with patients?
OncoPrecision is a platform therapeutics company leveraging high-throughput biology + AI/ML to integrate patients at every step of the discovery and development journey, from hypothesis …See details»
OncoPrecision - LinkedIn
OncoPrecision is a platform therapeutics company integrating patient-derived high-throughput biology with AI/ML to develop a pipeline of antibody-drug conjugates (ADCs) and bispecific antibodies ...See details»
OncoPrecision - BIO International Convention 2025
OncoPrecision Biotech or pharma, therapeutic R&D Our lead program features a highly selective first-in-class CD64-ADC leveraging a broad monocyte-depletion MoA, which has …See details»
OncoPrecision - Crunchbase Company Profile & Funding
OncoPrecision closed its last funding round on Jun 20, 2024 from a Convertible Note round. Who are OncoPrecision 's competitors? Alternatives and possible …See details»
OncoPrecision 2025 Company Profile: Valuation, Funding
OncoPrecision General Information Description. Developer of a patient micro avatar platform designed to get the right cancer therapy to the right patient. The company's platform leverages …See details»
OncoPrecision Company Profile - Office Locations, Competitors
OncoPrecision is a biotech company developing technologies for the treatment of oncology diseases. It provides a platform that focuses on obtaining cells from biopsies and recreating …See details»
OncoPrecision - The Org
OncoPrecision is a platform therapeutics company integrating high-throughput patient-derived biology with AI/ML to develop ADCs and bispecific antibodies with a high probability of success, focused on addressing unmet needs in …See details»
OncoPrecision - CEO and Investor Conference 2025 - bcic.bio.org
OncoPrecision is a platform therapeutics company leveraging patient-derived single-cell high-throughput biology + AI/ML to develop a pipeline of therapeutic antibodies (ADCs and BsAbs) …See details»
OncoPrecision - Products, Competitors, Financials, Employees ...
OncoPrecision Raises $3.3M Seed Funding to Improve Cancer Patient Outcomes and Drug Development Efforts with “Patient Micro Avatars” NEW YORK, October 31, 2022-- Today …See details»
Org of the Week: OncoPrecision
Apr 23, 2025 Founded in 2020 by Tarek Ali Zaki, Gastón Soria, Candelaria Llorens de los Ríos, and Gerardo Gatti, OncoPrecision is on a mission to increase the success of cancer therapies. …See details»
OncoPrecision - 2025 Company Profile - Tracxn
Apr 25, 2025 OncoPrecision - Developer of personalized assays for oncology precision therapy. Raised a total funding of $4.2M over 2 rounds from 6 investors. Founded by Gerardo Gatti and …See details»
OncoPrecision Raises $3.3M Seed Funding to Improve Cancer …
Oct 31, 2022 OncoPrecision was born as an idea that originated while Dr. Soria was leading his Synthetic Lethality Lab at the National University of Córdoba after returning from his …See details»
Battling cancer: How OncoPrecision is using AI to change the game
Oct 30, 2022 Battling cancer: How OncoPrecision is using AI to change the game. After raising $4.2m in pre-seed and seed funding, the Argentina-based biotech start-up is aiming to offer its …See details»
OncoPrecision - Overview, News & Similar companies - ZoomInfo
OncoPrecision Raises $3.3M Seed Funding to Improve Cancer Patient Outcomes and Drug Development Efforts with “Patient Micro Avatars” NEW YORK--(BUSINESS WIRE)--Today …See details»
OncoPrecision - SOSV
Oncoprecision.bio . Team Tarek Ali Zaki. Co-Founder & CEO. Gastón Soria. Co-Founder & CSO. Candelaria Llorens de los Ríos. Co-Founder & Director of Lab Operations. Gerardo Gatti. Co …See details»
ONCOPRECISION SAU
Find company research, competitor information, contact details & financial data for ONCOPRECISION SAU of Ciudad de Buenos Aires. Get the latest business insights from Dun …See details»
OncoPrecision: A matter of life and death - cancer avatars …
Jul 15, 2021 OncoPrecision can predict a patient’s response to cancer therapies by replicating the tumor microenvironment ex vivo. Their unique, triple co-culture method increases patient …See details»
OncoPrecision - IndieBio - #1 in Early Stage Biotech
Their unique, triple co-culture method increases patient-derived cancer cell viability 60x in a 2.5D format that has been validated using real patient data. For patients in dire need of the right …See details»
IndieBio’s OncoPrecision closes $3.3M seed round to personalize …
OncoPrecision creates functional assays for individual cancer patients to help oncologists determine a personalized and effective medication plan. With this most recent funding round, …See details»
BIO International Convention Opens in Boston, Showcasing Global ...
1 day ago The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanity. BOSTON (June 16, 2025) The BIO …See details»